Repairon’s mission is the development, the manufacture and the commercialisation of induced pluripotent stem cell (iPSC) based tissues for organ repair. Our lead commercial product are contractile heart tissue patches – Engineered Human Myocardium (EHM) - for the treatment of patients with advanced heart failure.
The medical need for regenerative therapies in advanced heart failure patients with high mortality and low quality of life is enormous. Existing therapies delay disease progression, but cannot repair the failing heart. The penultimate therapy, heart transplantation, is and will remain a therapeutic option only for very few patients. Implantation of contractile EHM-patches is a unique option to remuscularize the failing heart.
Our vision is that in the future, EHM-based therapies will make heart transplantation and mechanical circulatory support devices obsolete.